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LEUKOCYTE ABCA1 IMPEDES PROGRESSION OF ESTABLISHED
ATHEROSCLEROTIC LESIONS AFTER DIETARY CHOLESTEROL
LOWERING IN LDLR / MICE
Olga Snip, Janine Geerling, Miranda Van Eck. Leiden Academic Centre for
Drug Research, Leiden, The Netherlands
Aim: The ATP binding cassette transporter A1 (ABCA1) facilitates the
efﬂux of cholesterol and phospholipids to lipid free apolipoprotein A1 and
small dense high density lipoproteins. Various studies have shown that
leukocyte ABCA1 is an anti atherogenic factor. Dietary cholesterol
lowering stabilizes atherosclerotic lesions, however the role of ABCA1 in
this process is unknown. Therefore, this study aims to investigate the effect
of leukocyte ABCA1 on diet induced atherosclerotic lesions after with
drawal of the atherogenic diet.
Methods: Leukocyte ABCA1 was studied by transplanting bone marrow
cells from donor mice that were either knock out (ABCA1 / ) or wild type
for ABCA1 or that overexpressed ABCA1 (ABCA1Tg) into low density li
poprotein receptor knock out (LDLr / ) mice. All three groups of chimeric
mice were fed a Western type diet (WTD: 0.25%cholesterol, 15%cacao
butter) for 6 weeks to induce atherosclerotic lesion development. After
this period, a baseline group was sacriﬁced (ABCA1 / >LDLr / n¼12;
wild type >LDLr / n¼14; ABCA1Tg >LDLr / n¼9) for lesion assessment.
The remainder of chimeric mice was switched to a chow diet (low fat, no
added cholesterol) for 3 weeks to lower plasma cholesterol levels
(ABCA1 / >LDLr / n¼14; wild type >LDLr / n¼14; ABCA1Tg >LDLr /
n¼12).
Results: Withdrawal of the atherogenic diet normalized plasma choles
terol levels in all three groups. As a result, lesion development was sta
bilized in both the wild type >LDLr / and ABCA1Tg >LDLr / mice,
however not in the ABCA1 / >LDLr / mice, which displayed a 1.5 fold
increase (p<0.01) in atherosclerotic lesion size.
Conclusions: Leukocyte ABCA1 is required to halt atherosclerotic lesion
progression after dietary cholesterol lowering. Overexpression of ABCA1
did not result in any additional beneﬁcial effects.Fig. 1. Lesion size quantiﬁcation of Oil Red O stained atherosclerotic lesions in the
aortic roots.W1.1:2.
NON TOXIC CONCENTRATIONS OF CADMIUM ACCELERATE
SUBENDOTHELIAL RETENTION OF ATHEROGENIC LIPOPROTEINS IN
HUMANIZED ATHEROSCLEROSIS SUSCEPTIBLE MICE
Siavash Kijani, G€oran Bergstr€om, Malin Lindbom, Malin Levin, Lars
Barregård, Bj€orn Fagerberg, Per Fogelstrand, Jan Boren. Department of
Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska
University Hospital, Gothenburg, Sweden
Aim: Cadmium is an important risk factor for cardiovascular disease
(CVD). However, the underlying mechanism(s) are unclear. Cadmium has
been shown to increase proteoglycan synthesis in vitro. Because pro
teoglycans mediate a critical step in atherosclerosis by trapping apoB
containing lipoproteins in the artery wall, we hypothesized that cad
mium can increase proteoglycan mediated LDL binding and thereby
promote subendothelial LDL accumulation. Here we tested the
